Versigent (NYSE:VGNT – Get Free Report) released its earnings results on Tuesday. The company reported $999.00 EPS for the quarter, Zacks reports.
Versigent Stock Performance
VGNT stock traded up $1.31 during trading on Tuesday, hitting $37.48. 1,805,289 shares of the company traded hands, compared to its average volume of 3,587,132. Versigent has a 1 year low of $26.34 and a 1 year high of $37.68.
Analyst Upgrades and Downgrades
VGNT has been the subject of several research analyst reports. Deutsche Bank Aktiengesellschaft started coverage on Versigent in a research note on Tuesday, April 28th. They set a “hold” rating and a $35.00 price target for the company. Royal Bank Of Canada initiated coverage on Versigent in a research note on Tuesday, March 31st. They issued a “sector perform” rating and a $28.00 target price for the company. BNP Paribas Exane began coverage on shares of Versigent in a research report on Tuesday, April 28th. They set an “outperform” rating and a $41.00 price target on the stock. UBS Group assumed coverage on shares of Versigent in a report on Tuesday, April 14th. They issued a “buy” rating and a $43.00 price objective for the company. Finally, TD Cowen assumed coverage on shares of Versigent in a research note on Tuesday, April 14th. They issued a “buy” rating and a $47.00 price objective for the company. One investment analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $42.13.
Featured Stories
Receive News & Ratings for Versigent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Versigent and related companies with MarketBeat.com's FREE daily email newsletter.
